fluorescein has been researched along with Graves Ophthalmopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bernabei, F; Del Noce, C; Giannaccare, G; Pellegrini, M; Scotto, R; Senni, C; Traverso, CE; Vagge, A | 1 |
| Ichinose, A; Kakizaki, H; Takahashi, Y | 1 |
| Uy, HS; Yu, EN | 1 |
3 other study(ies) available for fluorescein and Graves Ophthalmopathy
| Article | Year |
|---|---|
In Vivo Confocal Microscopy Morphometric Analysis of Meibomian Glands in Patients With Graves Ophthalmopathy.
Topics: Adult; Case-Control Studies; Cell Count; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Male; Meibomian Gland Dysfunction; Meibomian Glands; Microscopy, Confocal; Middle Aged; Slit Lamp Microscopy; Staining and Labeling; Tears | 2021 |
Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
Topics: Administration, Topical; Adult; Aged; Alanine; Antioxidants; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Keratoconjunctivitis; Limbus Corneae; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Quinolones; Retrospective Studies; Rose Bengal; Tears; Treatment Outcome | 2014 |
Limbal relaxing incisions and Graves ophthalmopathy with lower eyelid retraction.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Astigmatism; Epithelium, Corneal; Exophthalmos; Eyelid Diseases; Fluorescein; Fluorophotometry; Functional Laterality; Graves Ophthalmopathy; Humans; Lens Implantation, Intraocular; Limbus Corneae; Lubricants; Male; Postoperative Complications; Reoperation; Wound Healing | 2009 |